In summary, we found a PD-L1+ CD49f+ CD133+ subpopulation of CTCs in patients with vulvar as well as cervical cancer whose presence was increased during therapy and was associated with cancer recurrence. The gene discussed is CD274; the disease is cervical carcinoma.